Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 2
2000 4
2001 2
2002 2
2003 2
2004 5
2005 7
2006 6
2007 7
2008 6
2009 4
2010 4
2011 9
2012 6
2013 8
2014 10
2015 11
2016 15
2017 17
2018 9
2019 11
2020 10
2021 11
2022 21
2023 8
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
Molnupiravir, an Oral Antiviral Treatment for COVID-19.
Fischer W, Eron JJ, Holman W, Cohen MS, Fang L, Szewczyk LJ, Sheahan TP, Baric R, Mollan KR, Wolfe CR, Duke ER, Azizad MM, Borroto-Esoda K, Wohl DA, Loftis AJ, Alabanza P, Lipansky F, Painter WP. Fischer W, et al. Among authors: wohl da. medRxiv. 2021 Jun 17:2021.06.17.21258639. doi: 10.1101/2021.06.17.21258639. Preprint. medRxiv. 2021. PMID: 34159342 Free PMC article. Updated.
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
Fischer WA 2nd, Eron JJ Jr, Holman W, Cohen MS, Fang L, Szewczyk LJ, Sheahan TP, Baric R, Mollan KR, Wolfe CR, Duke ER, Azizad MM, Borroto-Esoda K, Wohl DA, Coombs RW, James Loftis A, Alabanza P, Lipansky F, Painter WP. Fischer WA 2nd, et al. Among authors: wohl da. Sci Transl Med. 2022 Jan 19;14(628):eabl7430. doi: 10.1126/scitranslmed.abl7430. Epub 2022 Jan 19. Sci Transl Med. 2022. PMID: 34941423 Free article. Clinical Trial.
Reply.
Wohl DA, Golin CE, Napravnik S, Knight K, Flynn PM. Wohl DA, et al. J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e21-e22. doi: 10.1097/QAI.0000000000001457. J Acquir Immune Defic Syndr. 2017. PMID: 28796096 Free PMC article. No abstract available.
Viral and Symptom Rebound in Untreated COVID-19 Infection.
Deo R, Choudhary MC, Moser C, Ritz J, Daar ES, Wohl DA, Greninger AL, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, Li JZ; ACTIV-2/A5401 Study Team. Deo R, et al. Among authors: wohl da. medRxiv. 2022 Aug 2:2022.08.01.22278278. doi: 10.1101/2022.08.01.22278278. Preprint. medRxiv. 2022. PMID: 35982660 Free PMC article.
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection.
Bender Ignacio RA, Wohl DA, Arends R, Pilla Reddy V, Mu Y, Javan AC, Hughes MD, Eron JJ, Currier JS, Smith D, Chew KW, Gibbs M, Fletcher CV. Bender Ignacio RA, et al. Among authors: wohl da. Clin Pharmacol Ther. 2022 Dec;112(6):1207-1213. doi: 10.1002/cpt.2706. Epub 2022 Jul 26. Clin Pharmacol Ther. 2022. PMID: 35797235 Free PMC article. Clinical Trial.
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials.
Gupta SK, Post FA, Arribas JR, Eron JJ Jr, Wohl DA, Clarke AE, Sax PE, Stellbrink HJ, Esser S, Pozniak AL, Podzamczer D, Waters L, Orkin C, Rockstroh JK, Mudrikova T, Negredo E, Elion RA, Guo S, Zhong L, Carter C, Martin H, Brainard D, SenGupta D, Das M. Gupta SK, et al. Among authors: wohl da. AIDS. 2019 Jul 15;33(9):1455-1465. doi: 10.1097/QAD.0000000000002223. AIDS. 2019. PMID: 30932951 Free PMC article.
Antiretroviral therapy: when to start.
Sellers CJ, Wohl DA. Sellers CJ, et al. Among authors: wohl da. Infect Dis Clin North Am. 2014 Sep;28(3):403-20. doi: 10.1016/j.idc.2014.05.004. Infect Dis Clin North Am. 2014. PMID: 25151563 Free PMC article. Review.
Antimicrobial-resistant Enterobacterales colonization in people with HIV.
Henderson HI, Ruegsegger L, Alby K, Smedberg JR, Hill BM, Brown D, Wohl DA, Napravnik S, Van Duin D. Henderson HI, et al. Among authors: wohl da. JAC Antimicrob Resist. 2022 Aug 2;4(4):dlac082. doi: 10.1093/jacamr/dlac082. eCollection 2022 Aug. JAC Antimicrob Resist. 2022. PMID: 35935279 Free PMC article.
HIV-associated lipodystrophy syndrome.
Qaqish RB, Fisher E, Rublein J, Wohl DA. Qaqish RB, et al. Among authors: wohl da. Pharmacotherapy. 2000 Jan;20(1):13-22. doi: 10.1592/phco.20.1.13.34667. Pharmacotherapy. 2000. PMID: 10641972 Review.
New filovirus disease classification and nomenclature.
Kuhn JH, Adachi T, Adhikari NKJ, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH, Chertow DS, Chute CG, Cieslak TJ, Colebunders R, Crozier I, Davey RT, de Clerck H, Delgado R, Evans L, Fallah M, Fischer WA 2nd, Fletcher TE, Fowler RA, Grünewald T, Hall A, Hewlett A, Hoepelman AIM, Houlihan CF, Ippolito G, Jacob ST, Jacobs M, Jakob R, Jacquerioz FA, Kaiser L, Kalil AC, Kamara RF, Kapetshi J, Klenk HD, Kobinger G, Kortepeter MG, Kraft CS, Kratz T, Bosa HSK, Lado M, Lamontagne F, Lane HC, Lobel L, Lutwama J, Lyon GM 3rd, Massaquoi MBF, Massaquoi TA, Mehta AK, Makuma VM, Murthy S, Musoke TS, Muyembe-Tamfum JJ, Nakyeyune P, Nanclares C, Nanyunja M, Nsio-Mbeta J, O'Dempsey T, Pawęska JT, Peters CJ, Piot P, Rapp C, Renaud B, Ribner B, Sabeti PC, Schieffelin JS, Slenczka W, Soka MJ, Sprecher A, Strong J, Swanepoel R, Uyeki TM, van Herp M, Vetter P, Wohl DA, Wolf T, Wolz A, Wurie AH, Yoti Z. Kuhn JH, et al. Among authors: wohl da. Nat Rev Microbiol. 2019 May;17(5):261-263. doi: 10.1038/s41579-019-0187-4. Nat Rev Microbiol. 2019. PMID: 30926957 Free PMC article.
182 results